Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Elinafide

Copy Product Info
😃Good
Catalog No. T68061Cas No. 162706-37-8

Elinafide, a dinaphthylimide cytotoxic agent, is a DNA-targeted anticancer agent that has shown antitumor activity in in vitro and in vivo assays.

Elinafide

Elinafide

Copy Product Info
😃Good
Purity: 97.67%
Catalog No. T68061Cas No. 162706-37-8
Elinafide, a dinaphthylimide cytotoxic agent, is a DNA-targeted anticancer agent that has shown antitumor activity in in vitro and in vivo assays.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
5 mg$41In StockIn Stock
10 mg$64In StockIn Stock
25 mg$121In StockIn Stock
50 mg$167In StockIn Stock
100 mg$239In StockIn Stock
200 mg$335-In Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
This molecule is a custom-made product. TargetMol has an excellent synthesis team with the experience and capability to provide you with cost-effective products.If you have any questions, please feel free to contact us. We are committed to serving you wholeheartedly.
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:97.67%
Appearance:Solid
Color:Yellow
Contact us for more batch information

Resource Download

Product Introduction

Elinafide AI Summary
Elinafide demonstrates potent bioactivity by inhibiting cell growth in various human cancer cell cultures with low IC50 values. Specifically, it is effective against human colon carcinoma (HT-29) with an IC50 of 14.0 to 38.0 nM, human cervical carcinoma (HeLa) with an IC50 of 70.0 nM, human prostate carcinoma (PC-3) with IC50s ranging from 70.0 to 320.0 nM, and human breast cancer cell line MDA-MB-231 with an IC50 of 60.0 nM. Additionally, Elinafide shows selectivity towards leukemia cell lines and has cytotoxic effects against human NCI-H460 cells with an IC50 of 8.0 nM. In vivo, it has been observed to improve survival times in mouse models with M5076 murine sarcoma cells. These results suggest that Elinafide may hold promise as a potent and selective anticancer agent..
Note: Summary generated by AI. Data source: ChEMBL
Bioactivity
Description
Elinafide, a dinaphthylimide cytotoxic agent, is a DNA-targeted anticancer agent that has shown antitumor activity in in vitro and in vivo assays.
Targets&IC50
NCI-H460 cells:8 nM, Smooth muscle cells (SMCs):12 nM
Chemical Properties
Molecular Weight520.58
FormulaC31H28N4O4
Cas No.162706-37-8
SmilesO=C1C=2C=3C(C(=O)N1CCNCCCNCCN4C(=O)C=5C=6C(C4=O)=CC=CC6C=CC5)=CC=CC3C=CC2
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 1.3 mg/mL (2.5 mM), Sonication is recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM1.9209 mL9.6047 mL19.2093 mL96.0467 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Elinafide | purchase Elinafide | Elinafide cost | order Elinafide | Elinafide chemical structure | Elinafide formula | Elinafide molecular weight